Pathologie Hamburg West | Mammazentrum Hamburg am Krankenhaus Jerusalem
Kristina Wagner - Zytologieassistentin - Pathologie Hamburg-West GmbH | XING
Michelle Thönnes - Biologin - Pathologie Hamburg-West | XING
Cancers | Free Full-Text | Altona Prognostic Index: A New Prognostic Index for ER-Positive and Her2-Negative Breast Cancer of No Special Type
MVZ Prof. Niendorf Pathologie Hamburg-West GmbH in Hamburg
PDF) A compartment-specific transcriptome analysis reveals survival-relevant marker genes in the stroma fraction of squamous non-small cell lung cancer | Axel Stang - Academia.edu
Axel NIENDORF | Head of Institute | Professor
Your career at MVZ Prof. Dr. med. A. Niendorf Pathologie Hamburg-West GmbH | StepStone.
MVZ Prof. Dr. med. Niendorf Pathologie Hamburg-West GmbH - Institut für Histologie, Zytologie und molekulare Diagnostik | Dr. med. Incken Birthe Kilic
MVZ Prof. Dr. med. Niendorf Pathologie Hamburg-West GmbH - Institut für Histologie, Zytologie und molekulare Diagnostik | Hoch spezialisiert, genau und verlässlich.
Ultrastructural study of tumor cell differentiation in osteosarcoma of jaw bones<link href='#fn1'>*</link>
Pathologie Hamburg West ▷, Altona-Altstadt - Öffnungszeiten
Histopathologie | Jerusalem Hamburg
MVZ Prof. Dr. med. Niendorf Pathologie Hamburg-West GmbH - Institut für Histologie, Zytologie und molekulare Diagnostik | Grundsätze
Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature | PLOS ONE
PDF) Development of a Patient Decision Aid for Older Women With Stage I Breast Cancer Considering Adjuvant Treatment Postlumpectomy
Odontogenic Myxoma â•fl Clinical Concept and Morphological Studies<link href='#fn1'>*</link>
Pathologie Hamburg West | Individuelle Designleistungen Hamburg idel.org
PDF) Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor
Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature | PLOS ONE
